| Literature DB >> 28050894 |
Arnaud Gacouin1,2,3, Adel Maamar4,5,6, Pierre Fillatre4,5,6, Emmanuelle Sylvestre7,8,9, Margaux Dolan10, Yves Le Tulzo4,5,6, Jean Marc Tadié4,5,6.
Abstract
BACKGROUND: While the psychiatric disorders are conditions frequently encountered in hospitalized patients, there are little or no data regarding the characteristics and short- and long-term outcomes in patients with preexisting psychiatric disorders in ICU. Such assessment may provide the opportunity to determine the respective impact on mortality in the ICU and after ICU discharge with reasons for admission, including modalities of self-harm, of underlying psychiatric disorders and prior psychoactive medications.Entities:
Keywords: Cohort study; Critical care; Outcome; Psychiatric diagnoses; Psychoactive medication; Self-harm
Year: 2017 PMID: 28050894 PMCID: PMC5209316 DOI: 10.1186/s13613-016-0221-x
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Baseline characteristics of the study population
| Variables | Whole population |
|---|---|
| Age [years (mean ± SD)] | 43 ± 3 |
| Male gender [ | 814 (46) |
| SAPS II score, points (mean ± SD) | 34 ± 17 |
| Mental disorder [ | |
| Schizophrenia | 97 (6) |
| Non-schizophrenia psychiatric disorder | 237 (13) |
| Depression disorder | 1058 (60) |
| Bipolar disorder | 172 (10) |
| Anxiety disorder | 187 (11) |
| Substance dependence (alcohol and/or drug addiction) | 492 (28) |
| Transfer from psychiatric hospital or ward [ | 130 (7) |
| Psychoactive medication before admission [ | |
| None | 197 (11) |
| Benzodiazepines | 1043 (60) |
| Neuroleptics | 497 (28) |
| Antipsychotics other than neuroleptics | 175 (10) |
| Lithium | 81 (5) |
| SSRIs | 420 (24) |
| SNRIs | 34 (2) |
| Tri- or tetracyclics antidepressants | 226 (13) |
| MAOIs | 148 (8) |
| Admission following deliberate self-harm [ | 1280 (73) |
| Deliberate self-poisoning with psychoactive medications | |
| Alone | 1082 (62) |
| And/or with non-psychoactive medications | 139 (8) |
| And/or with pesticides, household, or industrial products | 28 (1.5) |
| And/or with hanging, drowning, jumping from buildings, or corrosive chemicals ingestion | 31 (1.5) |
| Admission for another reason than deliberate self-harm | 463 (27) |
| Respiratory failure | 165 (9) |
| Shock | 65 (4) |
| CNS or peripheral disorder | 82 (5) |
| Metabolic disorder | 53 (3) |
| Out-of-hospital cardiac arrest | 18 (1) |
| Acute kidney injury | 13 (0.5) |
| Non-deliberate psychoactive medication overdose | 44 (2.5) |
| Miscellaneous | 33 (2) |
| Chemical pneumonitis and/or aspiration pneumonia [ | 479 (27) |
| Organ support in the ICU [ | |
| Invasive mechanical ventilation | 1206 (69) |
| Vasopressors | 378 (22) |
| Renal replacement therapy | 176 (10) |
| ICU outcomes [ | |
| Acquired infection at any site | 64 (4) |
| Mortality | 91 (5) |
SAPS Simplified Acute Physiology Score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, MAOIs monoamine oxidase inhibitors
Baseline characteristics and outcomes compared between patients who died in the ICU and patients who survived the ICU stay
| Variable | Deceased patients | Surviving patients |
|
|---|---|---|---|
| Age [years (mean ± SD)] | 54 ± 17 | 45 ± 15 | <0.0001 |
| Male gender [ | 46 (51) | 766 (46) | 0.42 |
| SAPS II score, points (mean ± SD) | 69 ± 21 | 36 ± 15 | <0.0001 |
| Mental disorder [ | |||
| Schizophrenia | 3 (3) | 94 (6) | 0.48 |
| Non-schizophrenia psychiatric disorder | 16 (21) | 218 (13) | 0.04 |
| Depression disorder | 50 (55) | 1008 (60) | 0.27 |
| Bipolar disorder | 12 (13) | 160 (10) | 0.26 |
| Anxiety disorder | 7 (8) | 180 (11) | 0.48 |
| Substance dependence (alcohol and/or drug addiction) | 14 (15) | 478 (29) | 0.003 |
| Transfer from psychiatric hospital or ward [ | 14 (15) | 116 (7) | 0.003 |
| Psychoactive medication before admission [ | |||
| None | 9 (10) | 189 (11) | 0.66 |
| Benzodiazepines | 58 (64) | 1138 (68) | 0.33 |
| Neuroleptics | 26 (28) | 471 (28) | 0.97 |
| Antipsychotics other than neuroleptics | 10 (11) | 165 (10) | 0.74 |
| Lithium | 3 (3) | 78 (5) | 0.53 |
| SSRIs | 18 (20) | 402 (24) | 0.33 |
| SNRIs | 1 (1) | 33 (2) | 0.55 |
| Tri- or tetracyclics antidepressants | 11 (12) | 215 (13) | 0.81 |
| MAOIs | 8 (9) | 140 (8) | 0.90 |
| Reason for admission [ | |||
| Deliberate self-poisoning with psychoactive medications | |||
| Alone | 15 (16) | 1067 (64) | <0.0001 |
| And/or with non-psychoactive medications | 10 (11) | 129 (8) | 0.27 |
| And/or with pesticides, household, or industrial products | 0 (0) | 28 (2) | 0.40 |
| And/or with hanging, drowning, jumping from buildings, or corrosive chemicals ingestion | 13 (14) | 18 (1) | <0.0001 |
| Respiratory failure | 14 (15) | 151 (9) | 0.06 |
| Shock | 15 (16) | 50 (3) | <0.0001 |
| CNS or peripheral disorder | 6 (7) | 76 (6) | 0.31 |
| Metabolic disorder | 1 (1) | 52 (3) | 0.52 |
| Out-of-hospital cardiac arrest | 14 (15) | 4 (0.2) | <0.0001 |
| Acute kidney injury | 0 (0) | 13 (0.5) | 0.99 |
| Non-deliberate psychoactive medication overdose | 2 (2) | 42 (2.5) | 0.99 |
| Miscellaneous | 3 (3) | 30 (2) | 0.24 |
| Chemical pneumonitis and/or aspiration pneumonia [ | 28 (31) | 451 (27) | 0.45 |
| Organ support in the ICU [ | |||
| Invasive mechanical ventilation | 91 (100) | 1115 (67) | <0.0001 |
| Vasopressors | 84 (92) | 294 (18) | <0.0001 |
| Renal replacement therapy | 38 (42) | 138 (8) | <0.0001 |
| Acquired infection at any site | 14 (15) | 50 (3) | <0.0001 |
SAPS Simplified Acute Physiology Score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, MAOIs monoamine oxidase inhibitors
Unadjusted and adjusted 4-year prognostic analysis for the 1660 patients who survived the ICU stay
| Variable | Non adjusted hazard ratio | 95% Confident interval |
| Adjusted hazard ratio | 95% Confident interval |
|
|---|---|---|---|---|---|---|
| Age (1-year increment) | 1.053 | 1.041–1.066 | <0.0001 | 1.030 | 1.016–1.044 | <0.0001 |
| Male gender | 1.01 | 0.69–1.46 | 0.96 | |||
| SAPS II score (1-point increment) | 1.037 | 1.035–1.049 | <0.0001 | 1.023 | 1.010–1.036 | <0.01 |
| Mental disorder | ||||||
| Anxiety disorder | 0.47 | 0.21–1.07 | 0.07 | |||
| Schizophrenia | 1.67 | 0.87–3.20 | 0.12 | |||
| Psychotic disorder other than schizophrenia | 1.57 | 0.98–2.52 | 0.06 | |||
| Depression disorder | 0.80 | 0.55–1.16 | 0.24 | |||
| Bipolar disorder | 1.18 | 0.65–2.14 | 0.59 | |||
| Substance dependence (alcohol or drug addiction) | 1.12 | 0.79–1.16 | 0.42 | |||
| Transfer from psychiatric hospital or ward | 1.79 | 1.01–3.19 | 0.04 | |||
| Psychoactive medication before admission | ||||||
| None | 1.17 | 0.72–2.05 | 0.58 | |||
| Benzodiazepines | 0.97 | 0.80–1.90 | 0.80 | |||
| Neuroleptics | 1.16 | 0.78–1.72 | 0.47 | |||
| Antipsychotics other than neuroleptics | 1.08 | 0.80–1.47 | 0.60 | |||
| Lithium | 1.59 | 0.77–3.26 | 0.21 | |||
| SSRIs | 0.84 | 0.53–1.32 | 0.44 | |||
| SNRIs | 0.34 | 0.11–1.05 | 0.48 | |||
| Tri- or tetracyclics antidepressants | 0.52 | 0.21–1.27 | 0.52 | |||
| MAOIs | 0.89 | 0.63–1.24 | 0.42 | |||
| Reason for admission | ||||||
| Deliberate self-poisoning with psychoactive medications alone | 0.30 | 0.20–0.44 | <0.0001 | |||
| Deliberate self-poisoning with psychoactive medications and/or non-psychoactive medications | 0.11 | 0.10–0.78 | 0.03 | |||
| Deliberate self-poisoning with psychoactive medications and/or with pesticides, household or industrial products | 0.45 | 0.17–1.19 | 0.11 | |||
| Deliberate self-poisoning with psychoactive medications and/or with hanging, drowning, jumping from buildings or corrosive chemicals ingestion | 1.06 | 0.12–2.84 | 0.86 | |||
| Respiratory failure | 3.28 | 2.11–3.99 | <0.0001 | 2.33 | 1.19–4.57 | 0.01 |
| Shock | 6.30 | 3.76–5.92 | <0.0001 | 3.72 | 1.97–6.62 | <0.001 |
| CNS or peripheral disorder | 2.18 | 1.14–4.17 | 0.02 | |||
| Metabolic disorder | 1.50 | 0.61–3.67 | <0.38 | |||
| Out-of-hospital cardiac arrest | 4.52 | 0.63–7.79 | 0.13 | |||
| Acute kidney injury | 4.35 | 1.27–6.24 | 0.01 | |||
| Non-deliberate psychoactive medication overdose | 1.34 | 0.56–3.71 | 0.54 | |||
| Miscellaneous | 1.50 | 0.48–4.43 | 0.48 | |||
| Chemical pneumonitis and/or aspiration pneumonia [ | 1.18 | 0.67–1.57 | 0.99 | |||
| Organ support in the ICU | ||||||
| Invasive mechanical ventilation | 0.84 | 0.57–1.24 | 0.38 | |||
| Vasopressors | 2.01 | 1.39–3.10 | <0.0001 | |||
| Renal replacement therapy | 1.89 | 1.11–2.21 | 0.02 | |||
| ICU outcomes | ||||||
| Acquired infection at any site | 2.62 | 1.87–5.37 | <0.01 | |||
SAPS simplified acute physiologic score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, MAOIs monoamine oxidase inhibitors